Xbrane Biopharma: Follow-up Note on Submission Withdrawal
2022-05-31
Premium members 07:30
All readers 10:30
Redeye leaves a more elaborate comment on yesterday morning's news that Xbrane has withdrawn its Xlucane submission to the FDA.
Filip Einarsson
Disclosures and disclaimers